vepesid kapsel
bristol-myers squibb gyogyszerkereskedelmi kft. - etoposiid - kapsel - 100mg 10tk
lisinopril tablett
bristol laboratories limited - lisinopriil - tablett - 20mg 28tk
xermelo
serb sas - telotristat etipraat - carcinoid tumor; neuroendocrine tumors - muud seedetrakti ja ainevahetustooted - xermelo on näidustatud carcinoid sündroom kõhulahtisus koos somatostatiini analoog (ssa) ravi piisavalt kontrollitud, ssa ravi täiskasvanutel.
ionsys
incline therapeutics europe ltd - fentanüülvesinikkloriid - valu, postoperatiivne - valuvaigistid - täiskasvanud patsientidel on ionsys näidustatud ägeda mõõduka kuni raske postoperatiivse valu raviks.
onglyza
astrazeneca ab - saxagliptin - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.
moventig
kyowa kirin holdings b.v. - naloksegooli oksalaat - constipation; opioid-related disorders - perifeerne opioidi retseptori antagonistid, uimastid, kõhukinnisus - opioidi poolt indutseeritud kõhukinnisuse ravi (oic) täiskasvanud patsientidel, kellel on ebapiisav vastus lahtistidele (-lubadele).
zinplava
merck sharp & dohme b.v. - bezlotoxumab - pseudomembranoosne enterokoliit - suguhormoonid ja immunoglobuliinid, - zinplava on näidustatud clostridium difficile infektsiooni (cdi) kordumise ennetamiseks täiskasvanutel, kellel on kõrge risk cdi-d.